The utility of the Glasgow-Blatchford score in predicting clinical outcome and stratifying the need for therapeutic intervention in hospitalised patients with upper gastrointestinal bleeding: a prospective validating study.

Royal Adelaide Hospital0 个研究点目标入组 400 人开始时间: 2017年5月5日最近更新: 2020年3月23日

试验速览

暂无简介。

•Two groups of hospitalised patients, aged greater than or equal to 18 years, who present to, or at, the Royal Adelaide Hospital for the management of UGIH. The first group of patients will be those presenting to the ED with a primary diagnosis of UGIH. The second group of patients will be inpatients who develop an UGIH during their admission at the Royal Adelaide Hospital. UGIH is defined as bleeding from the upper gastrointestinal tract as manifested by haematemesis (including coffee-ground vomiting) and/or melaena. Both variceal and non-variceal causes of UGIH will be included in the study.

•1) Patients who are unable to give informed consent, and without the presence of a next of kin upon admission.
•2) Patients with urgent medical comorbidities, other than UGIH, which require inpatient admission.
•3) A known pre-existing cause of UGIH.
•4) Patients in whom outpatient follow-up cannot be guaranteed, including:
•a) Persons of no fixed address
•b) Rural and remote patients (only secondary outcomes can be measured, given that all patients in this category will be admitted)
•c) Patients with cognitive impairment
•d) Patients who live alone with inadequate adult supervision or social supports
•5) Pregnancy.

发起方